We are live on
!
Find out more
Sanders Capital Portfolio holdings
AUM
$83.9B
1-Year Est. Return
37.89%
This Fund
S&P 500
This Quarter
Est. Return
+5.34%
1 Year Est. Return
+37.89%
3 Year Est. Return
+120.64%
5 Year Est. Return
+154.21%
10 Year Est. Return
+678.77%
AUM
$16.6B
AUM Growth
+$1.03B
(+6.6%)
Cap. Flow
+$274M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
54.91%
Holding
39
New
1
Increased
24
Reduced
11
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$374M |
| 2 |
eBay
EBAY
|
+$101M |
| 3 |
Johnson & Johnson
JNJ
|
+$83.7M |
| 4 |
Medtronic
MDT
|
+$59.1M |
| 5 |
Citigroup
C
|
+$54.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$148M |
| 2 |
GE Aerospace
GE
|
+$133M |
| 3 |
Aptiv
APTV
|
+$126M |
| 4 |
D.R. Horton
DHI
|
+$117M |
| 5 |
Cigna
CI
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.82% |
| 2 | Technology | 24.38% |
| 3 | Financials | 16.41% |
| 4 | Consumer Discretionary | 9.31% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Omnicom Group
OMC
$23.4B
| $191M | 1.15% |
2,578,442
+5,000
| +0.2% | +$385K |
|
|
CAA
27
DELISTED
CalAtlantic Group, Inc.
CAA
| $160M | 0.97% |
4,380,539
+213,339
| +5% | +$7.59M |
|
28
BP
BP
$107B
| $151M | 0.91% |
4,343,166
-74,801
| -2% | -$2.38M |
|
29
Meritage Homes
MTH
$4.86B
| $141M | 0.85% |
6,357,158
-8,200
| -0.1% | -$171K |
|
30
Stanley Black & Decker
SWK
$15.7B
| $124M | 0.75% |
822,648
+22,000
| +3% | +$3.16M |
|
|
31
Aptiv
APTV
$10.3B
| $87.9M | 0.53% |
893,721
-1,338,315
| -60% | -$126M |
|
32
Synchrony
SYF
$25.6B
| $85.4M | 0.51% |
2,750,040
+69,717
| +3% | +$2.09M |
|
33
Genuine Parts
GPC
$18.7B
| $60.4M | 0.36% |
631,477
-383,600
| -38% | -$32.6M |
|
34
AbbVie
ABBV
$435B
| $55.8M | 0.34% |
627,533
| – | – |
|
35
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
| $25.4M | 0.15% |
481,136
+220,800
| +85% | +$11.4M |
|
36
Shinhan Financial Group
SHG
$35.6B
| $9.47M | 0.06% |
213,694
+24,100
| +13% | +$1.09M |
|
37
Barclays
BCS
$94.1B
| $5.36M | 0.03% |
541,246
-2,692
| -0.5% | -$26.7K |
|
38
Honda
HMC
$41.3B
| $4.8M | 0.03% |
162,481
| – | – |
|
|
39
GE Aerospace
GE
$384B
| – | – |
-1,031,216
| Closed | -$133M |
|
Similar funds
Sanders Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Sanders Capital held 39 positions worth $16.6B, up 6.6% from $15.6B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Sanders Capital's Q3 2017 filing shows 1 new, 24 increased, 11 reduced and 1 closed positions. Its largest new stake was Gilead Sciences: 4,884,478 shares worth $396M. The largest sale was Merck, an estimated $148M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- Sanders Capital's largest Q3 2017 buy was Gilead Sciences: 4,884,478 shares worth $396M.
- Sanders Capital added most to eBay in Q3 2017, an estimated $101M increase.
- Sanders Capital's biggest Q3 2017 reduction was Merck, cutting an estimated $148M.
- Sanders Capital fully exited GE Aerospace in Q3 2017, selling an estimated $133M.
- Sanders Capital's ten largest holdings make up 55% of its $16.6B portfolio in Q3 2017.
- Sanders Capital opened 1 new position and closed 1 in Q3 2017.
- Sanders Capital's portfolio value rose 6.6% quarter-over-quarter to $16.6B.
Based on Sanders Capital's 13F filing for Q3 2017, filed 19 Oct 2017.